FLORENCE, S.C. (AP) - Global drug maker Roche has announced that it’ll cease manufacturing at its Florence plant over the next two years.
Multiple media outlets report that the Swiss pharmaceutical company made the announcement Thursday. The company said it’ll seek to minimize the job losses by seeking a buyer for the factory, which has about 270 workers.
Roche is restructuring what it calls its underutilized “small molecules manufacturing network,” which includes the Florence plant and three others in Ireland, Italy and Spain. Those plants are also up for sale.
The company says the transition period will begin next year and be completed by 2018 in Florence and by 2021 in Europe.
Among the products Roche Carolina makes is Xeloda, an oral chemotherapy drug. Others include treatments for kidney disease and hepatitis C.
Copyright © 2021 The Washington Times, LLC.